Bharat Biotech forge partnership with University of Sydney

Dr Krishna Ella, Executive Chairman at Bharat Biotech, expressed enthusiasm about the agreement, stating, "This...

"Digital health is very important now...": Bharat Biotech

Speaking on the importance of health to ANI, Krishna Ella said, "I'm happy that we are having G20 in Hyderabad....

We dispatched nasal vaccines two days ago: Dr Krishna Ella

Speaking to ANI, Dr Krishna Ella said, "We just dispatched nasal vaccines two days ago to the hospitals."

UW-Madison Global Health Institute, Ella Foundation ink agreement

The Center is expected to be operational by end of 2023 and was announced at the UW-Madison Badger Utsav titled,...

'iNCOVACC' can produce three immune responses: Dr Krishna Ella

"It's easy to deliver and doesn't need any syringe or needle and most important it produces three immune responses,...

BB's COVID-19 nasal vaccine phase III trials completed

Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local...

Budget outlay in health sector, vaccine self-reliance has...

New Delhi [India], February 2 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Wednesday...

Bharat Biotech Chairman meets Vietnam Dy Health Min,...

New Delhi [India], December 18 (ANI): Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech along with...

Covaxin true success story of public-private partnership,...

New Delhi [India], November 24 (ANI): The development of the country's indigenous COVID-19 vaccine Covaxin is a true...

Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy...

Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet...

Booster dose of COVID-19 vaccine required if virus gets...

New Delhi [India], November 11 (ANI): People will need booster doses of the COVID-19 vaccine if the COVID-19...

After Covaxin gets WHO's EUL status, Bharat Biotech chief...

New Delhi [India], November 3 (ANI): After Bharat Biotech's Covaxin, was granted Emergency Use Listing (EUL) by the...